Pfizer to acquire Array BioPharma for $11.4bn

17-06-2019

Pfizer to acquire Array BioPharma for $11.4bn

manuelesteban / Shutterstock.com

US biopharmaceutical company Pfizer has entered agreed to acquire Array BioPharma, a biotechnology company which develops small molecule drugs for the treatment of cancer.


Pfizer, Array BioPharma, merger & acquisition, cancer, Braftovi, Mektovi

LSIPR